Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

Jakob Schöllhammer Knudsen, Reimar Wernich Thomsen, Anton Pottegård, Filip Krag Knop, Henrik Toft Sørensen

Original languageEnglish
JournalDiabetes Care
Volume41
Issue number9
Pages (from-to)e133-e135
Number of pages2
ISSN1935-5548
DOIs
Publication statusPublished - Sept 2018

Cite this